Aldesleukin Terminated Phase 1 Trials for Neuroblastomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01404702Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma